Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired |
gptkb:Vetoquinol_Canada
gptkb:Vetoquinol_USA |
| gptkbp:awards |
various industry awards
|
| gptkbp:brand_recognition |
strong brand recognition
|
| gptkbp:ceo |
gptkb:Jean-Michel_Dognin
|
| gptkbp:clinical_trial |
conducts clinical trials
|
| gptkbp:community_engagement |
supports local communities
|
| gptkbp:customer_base |
veterinarians
pet owners livestock producers animal owners |
| gptkbp:customer_feedback |
values customer feedback
|
| gptkbp:customer_support |
provides customer support services
|
| gptkbp:distribution_channels |
global distribution network
|
| gptkbp:employees |
approximately 1,000
|
| gptkbp:financial_performance |
gptkb:public_company
|
| gptkbp:financial_stability |
financially stable company
|
| gptkbp:focus |
animal health
|
| gptkbp:founded |
1933
|
| gptkbp:global_presence |
strong global presence
|
| gptkbp:headquarters |
gptkb:Lure,_France
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vetoquinol
|
| gptkbp:innovation |
focuses on innovative solutions
|
| gptkbp:invention |
holds multiple patents
|
| gptkbp:market |
conducts market research
|
| gptkbp:market_position |
leading veterinary pharmaceutical company
|
| gptkbp:marketing_strategy |
uses various marketing strategies
|
| gptkbp:mission |
improve animal health
|
| gptkbp:operates_in |
over 100 countries
|
| gptkbp:partnerships |
collaborates with universities
collaborates with research institutions various veterinary organizations |
| gptkbp:product |
ongoing product development
|
| gptkbp:product_line |
Vetoquinol products for cats
Vetoquinol products for dogs Vetoquinol products for horses Vetoquinol products for livestock |
| gptkbp:production_location |
multiple locations worldwide
|
| gptkbp:products |
antibiotics
nutraceuticals anti-inflammatories |
| gptkbp:regulatory_compliance |
complies with regulations
|
| gptkbp:research_and_development |
invests heavily
|
| gptkbp:research_focus |
animal welfare
animal diseases animal nutrition |
| gptkbp:revenue |
€200 million (2020)
|
| gptkbp:safety |
ensures product safety
|
| gptkbp:social_responsibility |
committed to social responsibility
|
| gptkbp:specializes_in |
veterinary pharmaceuticals
|
| gptkbp:stock_exchange |
gptkb:Euronext_Paris
|
| gptkbp:stock_symbol |
VETO
|
| gptkbp:subsidiaries |
gptkb:Vetoquinol_Canada
gptkb:Vetoquinol_Brazil gptkb:Vetoquinol_USA |
| gptkbp:supply_chain |
efficient supply chain management
|
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:training |
invests in employee training
|
| gptkbp:training_programs |
offers training programs for veterinarians
|
| gptkbp:vision |
be a leader in animal health
|
| gptkbp:website |
www.vetoquinol.com
|
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim_Animal_Health
|
| gptkbp:bfsLayer |
5
|